🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Priyanka Grover

Stock Analyst at J.P. Morgan

(0.13)
# 4,802
Out of 5,152 analysts
40
Total ratings
19.4%
Success rate
-25.4%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Priyanka Grover

BridgeBio Oncology Therapeutics
Nov 18, 2026
Maintained: Buy
Price Target: $17
Current: $1.98
Upside: +758.59%
Nuvation Bio
Nov 17, 2026
Maintained: Buy
Price Target: n/a
Current: $3.84
Upside: -
Neurogene
Nov 17, 2026
Maintained: Buy
Price Target: $63
Current: $23.30
Upside: +170.39%
Kura Oncology
Nov 17, 2026
Maintained: Buy
Price Target: $30 → $32
Current: $7.09
Upside: +351.34%
Recursion Pharmaceuticals
Nov 16, 2026
Rated: Buy
Price Target: $7
Current: $2.91
Upside: +140.96%
Arcus Biosciences
Nov 9, 2026
Rated: Buy
Price Target: $41 → $40
Current: $16.86
Upside: +137.25%
Rhythm Pharmaceuticals
Nov 6, 2026
Reiterated: Buy
Price Target: $145 → $142
Current: $107.48
Upside: +32.12%
Enliven Therapeutics
Oct 1, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $47.62
Upside: +57.50%
Mereo BioPharma Group
Sep 15, 2026
Reiterated: Sell
Price Target: n/a
Current: $0.305
Upside: -
Relay Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $31
Current: $17.27
Upside: +79.50%